Designed recombinant adenovirus type 5 vector induced env-specific CD8+ cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1
Ura T., Yoshida A., Xin K-Q., Yoshizaki S., Yashima S., Abe S, Mizuguchi H., Okuda K.